---
$id: https://graph.org.ai/products/commodity/51433923
$type: Product
source: UNSPSC
code: "51433923"
title: "Lacidipine"
class: "51433900"
classTitle: "Antihypertensive pyridines"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lacidipine

**UNSPSC Code**: 51433923
**Class**: [Antihypertensive pyridines](Antihypertensive pyridines.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a calcium channel blocker with the molecular formula C26H33NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 260080034N, chemically known as 1h-imidazole-5-methanol, 2-butyl-4-chloro-1-((2-(1h-tetrazol-5-yl)(1,1- biphenyl)-4-yl)methyl)- but generally known as lacidipine, which bears US NIH Compound Identifier 3961. European Medicines Agency schedules Lacidipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08383MIG. The term LACIDIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules lacidipine in its Anatomical Therapeutic Chemical (ATC) Classification. LACIDIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lacidipine under HS 29333999 and SITC 51574. As of Q4 2014, LACIDIPINE remains the US FDA Preferred Term for this commodity. Lacidipine bears US NLM identifiers UMLS ID C0064568 and NCI Concept Code C80881. SMILES: Clc1nc(n(Cc2ccc(cc2)c2c(cccc2)c2n[nH]nn2)c1CO)CCCC.

